DK1137645T3 - Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe - Google Patents

Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe

Info

Publication number
DK1137645T3
DK1137645T3 DK99963022T DK99963022T DK1137645T3 DK 1137645 T3 DK1137645 T3 DK 1137645T3 DK 99963022 T DK99963022 T DK 99963022T DK 99963022 T DK99963022 T DK 99963022T DK 1137645 T3 DK1137645 T3 DK 1137645T3
Authority
DK
Denmark
Prior art keywords
methylbenzyl
alpha
herpes viruses
phenylenediamine group
thiourea inhibitors
Prior art date
Application number
DK99963022T
Other languages
Danish (da)
English (en)
Inventor
Jonathan David Bloom
Kevin Joseph Curran
Russell George Dushin
Emily Boucher Norton
Adma Antonia Ross
Martin Joseph Digrandi
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1137645T3 publication Critical patent/DK1137645T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
DK99963022T 1998-12-09 1999-12-06 Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe DK1137645T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20890298A 1998-12-09 1998-12-09

Publications (1)

Publication Number Publication Date
DK1137645T3 true DK1137645T3 (da) 2004-08-09

Family

ID=22776519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99963022T DK1137645T3 (da) 1998-12-09 1999-12-06 Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe

Country Status (21)

Country Link
EP (1) EP1137645B1 (cs)
JP (1) JP2002531555A (cs)
KR (1) KR20010089551A (cs)
CN (1) CN1165531C (cs)
AR (1) AR035308A1 (cs)
AT (1) ATE267824T1 (cs)
AU (1) AU1934600A (cs)
BR (1) BR9916084A (cs)
CA (1) CA2350833A1 (cs)
CZ (1) CZ20012067A3 (cs)
DE (1) DE69917673T2 (cs)
DK (1) DK1137645T3 (cs)
EA (1) EA004205B1 (cs)
ES (1) ES2221470T3 (cs)
HU (1) HUP0104492A3 (cs)
IL (1) IL143183A0 (cs)
NO (1) NO20012833L (cs)
NZ (1) NZ512135A (cs)
PT (1) PT1137645E (cs)
WO (1) WO2000034260A2 (cs)
ZA (1) ZA200104376B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
ATE311366T1 (de) 2000-02-29 2005-12-15 Millennium Pharm Inc Benzamide und ähnliche inhibitoren vom faktor xa
AU8022901A (en) * 2000-08-21 2002-03-04 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
JP4360885B2 (ja) 2003-11-28 2009-11-11 富士フイルム株式会社 アルキルチオ基を有する芳香族アミン化合物の製造方法
EP1928843A1 (en) * 2005-08-22 2008-06-11 Amgen, Inc Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes
PT2077995E (pt) 2006-11-02 2012-05-10 Millennium Pharm Inc Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
CN115433093A (zh) * 2022-09-26 2022-12-06 无锡双启科技有限公司 一种3-氯-4-三氟甲基苯胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
EP0902782A1 (en) * 1996-04-23 1999-03-24 Vertex Pharmaceuticals Incorporated Urea derivatives as inhibitors of impdh enzyme

Also Published As

Publication number Publication date
AR035308A1 (es) 2004-05-12
WO2000034260A3 (en) 2000-09-08
KR20010089551A (ko) 2001-10-06
CN1165531C (zh) 2004-09-08
ATE267824T1 (de) 2004-06-15
JP2002531555A (ja) 2002-09-24
ZA200104376B (en) 2002-08-28
DE69917673T2 (de) 2005-06-09
CA2350833A1 (en) 2000-06-15
DE69917673D1 (de) 2004-07-01
NO20012833D0 (no) 2001-06-08
PT1137645E (pt) 2004-09-30
NZ512135A (en) 2003-12-19
HUP0104492A3 (en) 2002-12-28
EA200100638A1 (ru) 2001-12-24
CN1329608A (zh) 2002-01-02
IL143183A0 (en) 2002-04-21
EA004205B1 (ru) 2004-02-26
EP1137645B1 (en) 2004-05-26
WO2000034260A2 (en) 2000-06-15
EP1137645A2 (en) 2001-10-04
BR9916084A (pt) 2001-09-04
NO20012833L (no) 2001-08-02
HUP0104492A2 (hu) 2002-04-29
CZ20012067A3 (cs) 2001-10-17
AU1934600A (en) 2000-06-26
ES2221470T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE245142T1 (de) No-synthase inhibitoren
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
DK1049662T3 (da) Inhibitorer af alpha4-medieret celleadhæsion
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
DE69900356D1 (de) Nitro-Isoharnstoffderivate
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
IS5772A (is) Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum
NO20005795D0 (no) Antivirale forbindelser
DK1137632T3 (da) Thiourinstofinhibitorer af herpesvira
NO20012834D0 (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
ID23780A (id) Nitrik oksida penghambat infeksi phinovirus
DK1137645T3 (da) Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe
PL349217A1 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
IL143263A0 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
DK1102747T3 (da) Krystalformer af osenetant
NO20012836D0 (no) Tiourea-inhibitorer for herpes virus
DK0980241T3 (da) Gelatineindkapslede opløsningsdosisformer af sertralin
DK0949245T3 (da) Fremgangsmåde til alkylering af hindrede sulfonamider
DE69832262D1 (de) Druckempfindliches Korrekturtransferband
NO20012837D0 (no) Tiourea-inhibitorer for herpesvirus
DE69838855D1 (de) Kettenrad
DE59903701D1 (de) Mehrfachpackung